Free Trial

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive logo
$83.22 -1.06 (-1.26%)
Closing price 09/10/2025 03:59 PM Eastern
Extended Trading
$83.61 +0.39 (+0.47%)
As of 04:36 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
1
Hold
3
Buy
7

Based on 11 Wall Street analysts who have issued ratings for Colgate-Palmolive in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 11 analysts, 1 has given a sell rating, 3 have given a hold rating, and 7 have given a buy rating for CL.

Consensus Price Target

$98.00
17.76% Upside
According to the 11 analysts' twelve-month price targets for Colgate-Palmolive, the average price target is $98.00. The highest price target for CL is $107.00, while the lowest price target for CL is $83.00. The average price target represents a forecasted upside of 17.76% from the current price of $83.22.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CL Analyst Ratings Over Time

TypeCurrent Forecast
9/11/24 to 9/11/25
1 Month Ago
8/12/24 to 8/12/25
3 Months Ago
6/13/24 to 6/13/25
1 Year Ago
9/12/23 to 9/11/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
7 Buy rating(s)
10 Buy rating(s)
12 Buy rating(s)
Hold
3 Hold rating(s)
4 Hold rating(s)
9 Hold rating(s)
9 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$98.00$98.92$102.12$102.63
Forecasted Upside17.76% Upside16.48% Upside13.21% Upside-3.26% Downside
Consensus RatingModerate BuyModerate BuyHoldModerate Buy

CL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Colgate-Palmolive Stock vs. The Competition

TypeColgate-PalmoliveConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.55
2.54
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside17.76% Upside111.24% Upside11.30% Upside
News Sentiment Rating
Very Positive News

See Recent CL News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
8/4/2025Citigroup
2 of 5 stars
Filippo Falorni
Filippo Falorni
Not Rated
Lower TargetBuy$108.00 ➝ $105.00+25.93%
8/4/2025JPMorgan Chase & Co.
2 of 5 stars
Andrea Teixeira
Andrea Teixeira
Not Rated
Lower TargetOverweight$99.00 ➝ $95.00+13.76%
8/4/2025Morgan Stanley
3 of 5 stars
Dara Mohsenian
3 of 5 stars
Lower TargetOverweight$104.00 ➝ $96.00+15.10%
8/4/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetUnderweight$88.00 ➝ $83.00+0.03%
7/17/2025UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetBuy$109.00 ➝ $106.00+20.86%
7/15/2025Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetEqual Weight$86.00 ➝ $87.00-2.13%
3/31/2025Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOverweight$108.00 ➝ $107.00+15.39%
2/3/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetHold$95.00 ➝ $93.00+7.86%
2/3/2025Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$110.00 ➝ $105.00+21.20%
1/29/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSector Perform$101.00 ➝ $101.00+12.10%
1/8/2025TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetBuy$110.00 ➝ $100.00+14.53%
9/9/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 DowngradeBuyHold$107.00 ➝ $109.00+1.06%
8/1/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
7/30/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetMarket Perform$100.00 ➝ $103.00+3.00%
7/26/2024Hsbc Global Res
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyHold
7/26/2024HSBC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingBuyHold
7/24/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 DowngradeBuyHold$103.00 ➝ $95.00-1.61%
7/18/2024Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetOutperform$100.00 ➝ $106.00+6.91%
7/10/2024Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$100.00 ➝ $110.00+13.26%
6/24/2024BNP Paribas
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform$109.00+12.06%
5/15/2024Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$97.00 ➝ $107.00+13.01%
3/1/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Initiated CoverageBuy$93.00+7.50%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:27 AM ET.


Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, September 10, 2025. Please send any questions or comments about these Colgate-Palmolive pros and cons to contact@marketbeat.com.

Colgate-Palmolive
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Colgate-Palmolive:

  • Colgate-Palmolive recently reported earnings per share (EPS) of $0.92, exceeding analysts' expectations, which indicates strong financial performance and potential for growth.
  • The company has a robust net margin of 14.55%, suggesting effective cost management and profitability, which can lead to higher returns for investors.
  • Colgate-Palmolive has declared a quarterly dividend of $0.52, translating to an annualized dividend yield of approximately 2.5%, providing a steady income stream for shareholders.
  • With a return on equity of 377.63%, Colgate-Palmolive demonstrates exceptional efficiency in generating profits from shareholders' equity, which is attractive for long-term investors.
  • The current stock price is around $98, which is considered reasonable given the company's strong fundamentals and growth prospects, making it an appealing investment opportunity.

Colgate-Palmolive
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Colgate-Palmolive for these reasons:

  • Despite recent earnings growth, the company's revenue only increased by 1.0% compared to the same quarter last year, indicating potential challenges in driving sales growth.
  • Several analysts have downgraded their target prices for Colgate-Palmolive, reflecting concerns about future performance and market conditions.
  • The payout ratio of 58.43% suggests that a significant portion of earnings is being distributed as dividends, which may limit the company's ability to reinvest in growth opportunities.
  • Market sentiment appears mixed, with a consensus rating of "Moderate Buy," indicating that while some analysts are optimistic, others have reservations about the stock's potential.
  • Colgate-Palmolive operates in a competitive consumer goods market, which can impact its pricing power and market share, posing risks to future profitability.

CL Forecast - Frequently Asked Questions

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Colgate-Palmolive is $98.00, with a high forecast of $107.00 and a low forecast of $83.00.

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There is currently 1 sell rating, 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CL shares.

According to analysts, Colgate-Palmolive's stock has a predicted upside of 17.76% based on their 12-month stock forecasts.

Colgate-Palmolive has been rated by research analysts at Barclays, Citigroup, JPMorgan Chase & Co., Morgan Stanley, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like Colgate-Palmolive more than other "consumer staples" companies. The consensus rating score for Colgate-Palmolive is 2.55 while the average consensus rating score for "consumer staples" companies is 2.53. Learn more on how CL compares to other companies.


This page (NYSE:CL) was last updated on 9/11/2025 by MarketBeat.com Staff
From Our Partners